JAGSNPHARMNSEJagsonpal Pharmaceuticals Limited· PharmaceuticalsLowNeutral
Announced Tue, 4 Nov · 17:11 IST

Jagsonpal Pharmaceuticals Limited has informed the Exchange about Link of Recording

Investor Communications View source PDF

JAGSNPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Jagsonpal Pharmaceuticals has shared the audio recording link of its Q2 FY26 Earnings Conference Call held on November 4, 2025, at 2:00 PM. The recording is now available on the company's website under the Investor Relations > Earnings Calls section. This is a routine compliance filing under SEBI Listing Regulations, following up on an earlier intimation dated October 29, 2025. No financial details, guidance, or management commentary are included in this particular filing.

Likely market impact

No direct impact on shareholders or stock price — this is purely a procedural disclosure. Investors interested in management's commentary on Q2 results and outlook can listen to the audio recording for qualitative insights.